Skip to contentO
Opus Genetics, Inc.
O
IRDOpus Genetics, Inc. Q1 2017 · 10-Q
Revenue—
Net Income-$21.61M-$21.61MN/M vs Q1 2016 EPS Diluted-$0.91-$0.91N/M vs Q1 2016 Operating Income-$3,953,241N/M Operating Cash Flow-$4,168,735N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 3, 2017 · 33 d after period end